한빛사논문
Hyuk Sung Kwon 1, Ji Young Kim 2, Seong-Ho Koh 1, Seong Hye Choi 3, Eun-Hye Lee 1, Jee Hyang Jeong 4, Jae-Won Jang 5, Kyung Won Park 6, Eun-Joo Kim 7, Jin Yong Hong 8, Soo Jin Yoon 9, Bora Yoon 10, Hyun-Hee Park 1, Myung Hoon Han 11
1Department of Neurology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Republic of Korea.
2Department of Nuclear Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Republic of Korea.
3Department of Neurology, Inha University College of Medicine, Incheon, Republic of Korea.
4Department of Neurology, Ewha Womans University School of Medicine, Seoul, Republic of Korea.
5Department of Neurology, Kangwon National University School of Medicine, Chuncheon, Republic of Korea.
6Department of Neurology, Dong-A Medical Center, Dong-A University College of Medicine, Busan, Republic of Korea.
7Department of Neurology, Pusan National University Hospital, Pusan National University School of Medicine and Medical Research Institute, Busan, Republic of Korea.
8Department of Neurology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
9Department of Neurology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Republic of Korea.
10Department of Neurology, Konyang University College of Medicine, Daejeon, Republic of Korea.
11Department of Neurosurgery, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Republic of Korea.
Hyuk Sung Kwon and Ji Young Kim are equal first authors.
Seong-Ho Koh and Seong Hye Choi contributed equally as co-senior authors.
CORRESPONDING AUTHOR : Seong-Ho Koh
Abstract
Background: A combination of plasma phospho-tau (p-tau), amyloid beta (Aβ)-positron emission tomography (PET), brain magnetic resonance imaging, cognitive function tests, and other biomarkers might predict future cognitive decline. This study aimed to investigate the efficacy of combining these biomarkers in predicting future cognitive stage transitions within 3 years.
Methods: Among the participants in the Korean Brain Aging Study for the Early Diagnosis and Prediction of Alzheimer's Disease (KBASE-V) study, 49 mild cognitive impairment (MCI) and 113 cognitively unimpaired (CU) participants with Aβ-PET and brain imaging data were analyzed.
Results: Older age, increased plasma p-tau181, Aβ-PET positivity, and decreased semantic fluency were independently associated with cognitive stage transitions. Combining age, p-tau181, the Centiloid scale, semantic fluency, and hippocampal volume produced high predictive value in predicting future cognitive stage transition (area under the curve = 0.879).
Conclusions: Plasma p-tau181 and Centiloid scale alone or in combination with other biomarkers, might predict future cognitive stage transition in non-dementia patients.
Highlights: -Plasma p-tau181 and Centiloid scale might predict future cognitive stage transition. -Combining them or adding other biomarkers increased the predictive value. -Factors that independently associated with cognitive stage transition were demonstrated.
논문정보
관련 링크
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기